$LXRP - Lexaria has patented and commercialized th

$LXRP - Lexaria has patented and commercialized the world’s newest drug delivery technology (DehydraTECH™) that has been both laboratory and market proven to enhance the performance of several categories of drugs, always in oral and/or topical product formats:

NSAIDs
Nicotine
Anti-Viral
Cannabinoids
Vitamins
Phosphodiesterase Inhibitors


Lexaria’s technology is easily applied through incorporation of an intermediate step in the formulation and manufacturing of existing or new orally-ingestible and topical products. This step involves mixing the beneficial compound of interest as a delivery “payload” together with certain fatty acids, infusing the mixture into a substrate material, and then using controlled dehydration synthesis processing to conjugate the payload and fatty acids together at a molecular level before integrating the newly-combined molecules into production.

The result: $LXRP - Lexaria Biosciences can now utilize this process to produce medicines, dietary supplements, pills, capsules, foods, candies and even beverages without the degradation typically experienced by all other delivery methodologies. This technology is a sea change in the way cannabis is delivered to the human body, and it allows nearly complete bioavailability.


Kgem